AAAAAA

   
Results: 1-7 |
Results: 7
SAFETY AND COST-EFFECTIVENESS OF A 10 X 10(9) L TRIGGER FOR PROPHYLACTIC PLATELET TRANSFUSIONS COMPARED WITH THE TRADITIONAL 20 X 10(9)/L TRIGGER - A PROSPECTIVE COMPARATIVE TRIAL IN 105 PATIENTS WITH ACUTE MYELOID-LEUKEMIA/
Authors: WANDT H FRANK M EHNINGER G SCHNEIDER C BRACK N DAOUD A FACKLERSCHWALBE I FISCHER J GACKLE R GEER T HARMS P LOFFLER B OHL S OTREMBA B RAAB M SCHONROCKNABULSI P STROBEL G WINTER R LINK H
Citation: H. Wandt et al., SAFETY AND COST-EFFECTIVENESS OF A 10 X 10(9) L TRIGGER FOR PROPHYLACTIC PLATELET TRANSFUSIONS COMPARED WITH THE TRADITIONAL 20 X 10(9)/L TRIGGER - A PROSPECTIVE COMPARATIVE TRIAL IN 105 PATIENTS WITH ACUTE MYELOID-LEUKEMIA/, Blood, 91(10), 1998, pp. 3601-3606
GERM-CELL TUMORS (GCT) IN MEN WITH HIV-INFECTION
Authors: HENTRICH M BRACK N SCHUSTER T CLEMM C HARTENSTEIN R
Citation: M. Hentrich et al., GERM-CELL TUMORS (GCT) IN MEN WITH HIV-INFECTION, European journal of cancer, 33, 1997, pp. 172-172
INFLUENCE OF LONG-TERM STORAGE OF FRESHLY EXPLANTED TUMOR-CELLS ON IN-VITRO SOFT AGAR CLONING
Authors: PETER R ADOLPHSEN N DEPENBROCK H BUDAK G SCHMID P BRACK N RASTETTER J HANAUSKE AR
Citation: R. Peter et al., INFLUENCE OF LONG-TERM STORAGE OF FRESHLY EXPLANTED TUMOR-CELLS ON IN-VITRO SOFT AGAR CLONING, European journal of cancer, 33, 1997, pp. 819-819
INTENSIVE POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL
Authors: HUBNER G LINK H SCHONROCKNABULSI P WANDT H GRAMATZKI M LOFFLER B FACKLERSCHWALBE I QUEISSER W BRACK N GEER T RAAB M OHL S SCHNEIDER B SCHNEIDER C FREUND M POLIWODA H EHNINGER G
Citation: G. Hubner et al., INTENSIVE POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL, Medizinische Klinik, 91, 1996, pp. 26-32
XPS AND SIMS INVESTIGATION OF COVALENTLY BOUND LIPID ON THE WOOL FIBER SURFACE
Authors: BRACK N LAMB R PHAM D TURNER P
Citation: N. Brack et al., XPS AND SIMS INVESTIGATION OF COVALENTLY BOUND LIPID ON THE WOOL FIBER SURFACE, Surface and interface analysis, 24(10), 1996, pp. 704-710
ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH HIGH-DOSE ARA-C POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA
Authors: LINK H EHNINGER G",SCHONROCKNABULSI,GRAMATZKI,"FRANKE A EINSELE H TISCHLER J BRACK N OTREMBA B LUTZ M GACKLE R OHL S HEIDEMANN E WILHELM M LOFFLER B WEISS J GEER T DIEHL S WANDT H
Citation: H. Link et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH HIGH-DOSE ARA-C POSTREMISSION THERAPY IN ACUTE MYELOID-LEUKEMIA, Blood, 88(10), 1996, pp. 2723-2723
AGGRESSIVE CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, AMSACRIN, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR ADVANCED MYELODYSPLASTIC SYNDROMES AND HIGH-RISK ANLL
Authors: GANSER A HEIL G HOFMANN WK OTTMANN OG SEIPELT G FISCHER JT LANGER W BROCKHAUS W ITTEL TH BRACK N KNUTH A HOFFKEN K KLAUSMANN M FUHR HG BERGMANN L HOELZER D
Citation: A. Ganser et al., AGGRESSIVE CHEMOTHERAPY WITH IDARUBICIN, ARA-C, VP-16, AMSACRIN, FOLLOWED BY G-CSF AND MAINTENANCE IMMUNOTHERAPY WITH INTERLEUKIN-2 FOR ADVANCED MYELODYSPLASTIC SYNDROMES AND HIGH-RISK ANLL, Blood, 86(10), 1995, pp. 1722-1722
Risultati: 1-7 |